Application 216185
- Type
- NDA
- Sponsor
- AUCTA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | MOTPOLY XR | LACOSAMIDE | CAPSULE, EXTENDED RELEASE;ORAL | 100MG | Yes | No |
| 002 | MOTPOLY XR | LACOSAMIDE | CAPSULE, EXTENDED RELEASE;ORAL | 150MG | Yes | No |
| 003 | MOTPOLY XR | LACOSAMIDE | CAPSULE, EXTENDED RELEASE;ORAL | 200MG | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N216185-001 | MOTPOLY XR | LACOSAMIDE | 100MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2023-05-04 | |
| N216185-002 | MOTPOLY XR | LACOSAMIDE | 150MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2023-05-04 | |
| N216185-003 | MOTPOLY XR | LACOSAMIDE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD, RS | 2023-05-04 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N216185-001 | 11337943 | 2040-06-05 | U-3660 | Drug product | 2023-08-01 |
| N216185-001 | 11337943 | 2040-06-05 | U-3954 | Drug product | 2023-08-01 |
| N216185-001 | 11883374 | 2040-06-05 | U-3660 | Drug product | 2024-08-21 |
| N216185-001 | 11883374 | 2040-06-05 | U-3954 | Drug product | 2024-08-21 |
| N216185-001 | 12042474 | 2040-06-05 | U-3660 | Drug product | 2024-08-21 |
| N216185-001 | 12042474 | 2040-06-05 | U-3954 | Drug product | 2024-08-21 |
| N216185-002 | 11337943 | 2040-06-05 | U-3660 | Drug product | 2023-08-01 |
| N216185-002 | 11337943 | 2040-06-05 | U-3954 | Drug product | 2023-08-01 |
| N216185-002 | 11883374 | 2040-06-05 | U-3660 | Drug product | 2024-08-21 |
| N216185-002 | 11883374 | 2040-06-05 | U-3954 | Drug product | 2024-08-21 |
| N216185-002 | 12042474 | 2040-06-05 | U-3660 | Drug product | 2024-08-21 |
| N216185-002 | 12042474 | 2040-06-05 | U-3954 | Drug product | 2024-08-21 |
| N216185-003 | 11337943 | 2040-06-05 | U-3660 | Drug product | 2023-08-01 |
| N216185-003 | 11337943 | 2040-06-05 | U-3954 | Drug product | 2023-08-01 |
| N216185-003 | 11883374 | 2040-06-05 | U-3660 | Drug product | 2024-08-21 |
| N216185-003 | 11883374 | 2040-06-05 | U-3954 | Drug product | 2024-08-21 |
| N216185-003 | 12042474 | 2040-06-05 | U-3660 | Drug product | 2024-08-21 |
| N216185-003 | 12042474 | 2040-06-05 | U-3954 | Drug product | 2024-08-21 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2024-10-29 15:01 UTC | 2024-10 | N216185-002 | MOTPOLY XR | 150MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2023-05-04 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N216185-003 | MOTPOLY XR | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD, RS | 2023-05-04 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N216185-001 | MOTPOLY XR | 100MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2023-05-04 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N216185-002 | MOTPOLY XR | 150MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2023-05-04 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N216185-003 | MOTPOLY XR | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD, RS | 2023-05-04 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N216185-001 | MOTPOLY XR | 100MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2023-05-04 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N216185-002 | MOTPOLY XR | 150MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2023-05-04 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N216185-003 | MOTPOLY XR | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD, RS | 2023-05-04 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N216185-001 | MOTPOLY XR | 100MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2023-05-04 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N216185-002 | MOTPOLY XR | 150MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2023-05-04 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N216185-003 | MOTPOLY XR | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD, RS | 2023-05-04 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N216185-001 | MOTPOLY XR | 100MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2023-05-04 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | N216185-002 | MOTPOLY XR | 150MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2023-05-04 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | N216185-003 | MOTPOLY XR | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD, RS | 2023-05-04 | 8072bd15b7f6… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N216185-001 | MOTPOLY XR | 100MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2023-05-04 | 6a51e52b5d6a… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N216185-002 | MOTPOLY XR | 150MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2023-05-04 | 6a51e52b5d6a… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N216185-003 | MOTPOLY XR | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD, RS | 2023-05-04 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | N216185-001 | MOTPOLY XR | 100MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2023-05-04 | 1c564ffb4f44… | |
| 2024-02-18 07:12 UTC | 2024-02 | N216185-002 | MOTPOLY XR | 150MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2023-05-04 | 1c564ffb4f44… | |
| 2024-02-18 07:12 UTC | 2024-02 | N216185-003 | MOTPOLY XR | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD, RS | 2023-05-04 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | N216185-001 | MOTPOLY XR | 100MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2023-05-04 | ea1830bbd6c7… | |
| 2023-12-20 04:57 UTC | 2023-12 | N216185-002 | MOTPOLY XR | 150MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2023-05-04 | ea1830bbd6c7… | |
| 2023-12-20 04:57 UTC | 2023-12 | N216185-003 | MOTPOLY XR | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD, RS | 2023-05-04 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N216185-001 | MOTPOLY XR | 100MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2023-05-04 | a72a2bbeb626… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N216185-002 | MOTPOLY XR | 150MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2023-05-04 | a72a2bbeb626… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N216185-003 | MOTPOLY XR | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD, RS | 2023-05-04 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N216185-001 | MOTPOLY XR | 100MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2023-05-04 | 9b2671bbb829… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N216185-002 | MOTPOLY XR | 150MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2023-05-04 | 9b2671bbb829… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N216185-003 | MOTPOLY XR | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD, RS | 2023-05-04 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N216185-001 | MOTPOLY XR | 100MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2023-05-04 | a67488948f0b… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N216185-002 | MOTPOLY XR | 150MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2023-05-04 | a67488948f0b… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N216185-003 | MOTPOLY XR | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD, RS | 2023-05-04 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N216185-001 | MOTPOLY XR | 100MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2023-05-04 | 3f0d92c62455… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N216185-002 | MOTPOLY XR | 150MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2023-05-04 | 3f0d92c62455… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N216185-003 | MOTPOLY XR | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD, RS | 2023-05-04 | 3f0d92c62455… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N216185-001 | MOTPOLY XR | 100MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2023-05-04 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N216185-002 | MOTPOLY XR | 150MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2023-05-04 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N216185-003 | MOTPOLY XR | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD, RS | 2023-05-04 | a50c72e98297… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | N216185-001 | 11337943 | 2040-06-05 | U-3660 | Drug product | 2023-08-01 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N216185-001 | 11337943 | 2040-06-05 | U-3954 | Drug product | 2023-08-01 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N216185-001 | 11883374 | 2040-06-05 | U-3660 | Drug product | 2024-08-21 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N216185-001 | 11883374 | 2040-06-05 | U-3954 | Drug product | 2024-08-21 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N216185-001 | 12042474 | 2040-06-05 | U-3660 | Drug product | 2024-08-21 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N216185-001 | 12042474 | 2040-06-05 | U-3954 | Drug product | 2024-08-21 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N216185-002 | 11337943 | 2040-06-05 | U-3660 | Drug product | 2023-08-01 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N216185-002 | 11337943 | 2040-06-05 | U-3954 | Drug product | 2023-08-01 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N216185-002 | 11883374 | 2040-06-05 | U-3954 | Drug product | 2024-08-21 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N216185-002 | 11883374 | 2040-06-05 | U-3660 | Drug product | 2024-08-21 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N216185-002 | 12042474 | 2040-06-05 | U-3954 | Drug product | 2024-08-21 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N216185-002 | 12042474 | 2040-06-05 | U-3660 | Drug product | 2024-08-21 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N216185-003 | 11337943 | 2040-06-05 | U-3660 | Drug product | 2023-08-01 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N216185-003 | 11337943 | 2040-06-05 | U-3954 | Drug product | 2023-08-01 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N216185-003 | 11883374 | 2040-06-05 | U-3954 | Drug product | 2024-08-21 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N216185-003 | 11883374 | 2040-06-05 | U-3660 | Drug product | 2024-08-21 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N216185-003 | 12042474 | 2040-06-05 | U-3954 | Drug product | 2024-08-21 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N216185-003 | 12042474 | 2040-06-05 | U-3660 | Drug product | 2024-08-21 | d4dbc9d85df4… |
| 2026-10-15 13:18:30 | 2026-09 | N216185-001 | 11337943 | 2040-06-05 | U-3660 | Drug product | 2023-08-01 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N216185-001 | 11337943 | 2040-06-05 | U-3954 | Drug product | 2023-08-01 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N216185-001 | 11883374 | 2040-06-05 | U-3660 | Drug product | 2024-08-21 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N216185-001 | 11883374 | 2040-06-05 | U-3954 | Drug product | 2024-08-21 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N216185-001 | 12042474 | 2040-06-05 | U-3660 | Drug product | 2024-08-21 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N216185-001 | 12042474 | 2040-06-05 | U-3954 | Drug product | 2024-08-21 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N216185-002 | 11337943 | 2040-06-05 | U-3660 | Drug product | 2023-08-01 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N216185-002 | 11337943 | 2040-06-05 | U-3954 | Drug product | 2023-08-01 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N216185-002 | 11883374 | 2040-06-05 | U-3954 | Drug product | 2024-08-21 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N216185-002 | 11883374 | 2040-06-05 | U-3660 | Drug product | 2024-08-21 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N216185-002 | 12042474 | 2040-06-05 | U-3954 | Drug product | 2024-08-21 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N216185-002 | 12042474 | 2040-06-05 | U-3660 | Drug product | 2024-08-21 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N216185-003 | 11337943 | 2040-06-05 | U-3660 | Drug product | 2023-08-01 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N216185-003 | 11337943 | 2040-06-05 | U-3954 | Drug product | 2023-08-01 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N216185-003 | 11883374 | 2040-06-05 | U-3954 | Drug product | 2024-08-21 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N216185-003 | 11883374 | 2040-06-05 | U-3660 | Drug product | 2024-08-21 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N216185-003 | 12042474 | 2040-06-05 | U-3954 | Drug product | 2024-08-21 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N216185-003 | 12042474 | 2040-06-05 | U-3660 | Drug product | 2024-08-21 | c2088c7a36db… |
| 2026-09-14 22:38:34 | 2026-08 | N216185-001 | 11337943 | 2040-06-05 | U-3660 | Drug product | 2023-08-01 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N216185-001 | 11337943 | 2040-06-05 | U-3954 | Drug product | 2023-08-01 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N216185-001 | 11883374 | 2040-06-05 | U-3660 | Drug product | 2024-08-21 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N216185-001 | 11883374 | 2040-06-05 | U-3954 | Drug product | 2024-08-21 | 84e616aacf4f… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| MOTPOLY XR | LACOSAMIDE | Aucta Pharmaceuticals, Inc. | fb8235b4-4cd3-6f22-e053-6294a90a545c | 2025-07-16 | Warnings, Adverse reactions | 216185 NDA216185 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.